REG-BARCLAYS PLC Form 8.3 - WILLIS TOWERS WATSON PLC
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20210215:nBw4r8WPsa&default-theme=true
Form 8.3 - WILLIS TOWERS WATSON PLC
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER
RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR
MORE
1. KEY INFORMATION
Name of person dealing (Note 1) Barclays PLC.
Company dealt in WILLIS TOWERS WATSON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 12 February 2021
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant
security dealt in (Note 3)
Class of relevant security: ORD
Long Short
Number (%) Number (%)
(1) Relevant securities
2,101,689 1.63% 609,883 0.47%
(2) Derivatives (other than options):
273,127 0.21% 318,405 0.25%
(3) Options and agreements to
purchase/sell: 6,000 0.00% 6,000 0.00%
TOTAL:
2,380,816 1.85% 934,288 0.72%
(b) Interests and short positions in relevant securities of the company, other
than the class dealt in (Note 3)
Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit
Purchase 1 226.6900 USD
Purchase 1 226.5500 USD
Purchase 4 227.3987 USD
Purchase 5 228.1100 USD
Purchase 5 228.1200 USD
Purchase 8 226.5100 USD
Purchase 8 226.4400 USD
Purchase 8 227.4500 USD
Purchase 8 227.4050 USD
Purchase 8 227.2900 USD
Purchase 16 226.9250 USD
Purchase 30 229.3800 USD
Purchase 32 226.9100 USD
Purchase 39 227.9140 USD
Purchase 100 226.2000 USD
Purchase 100 226.4900 USD
Purchase 100 226.8300 USD
Purchase 100 227.0400 USD
Purchase 100 229.6710 USD
Purchase 131 229.6119 USD
Purchase 142 226.9409 USD
Purchase 418 229.7954 USD
Purchase 933 227.8866 USD
Purchase 1,300 227.0538 USD
Purchase 2,857 227.7870 USD
Purchase 2,890 227.4841 USD
Purchase 2,909 229.2076 USD
Purchase 3,014 227.4200 USD
Purchase 3,385 227.4608 USD
Purchase 6,542 226.9812 USD
Purchase 60,004 227.9222 USD
Sale 6 226.3900 USD
Sale 8 227.4500 USD
Sale 10 227.8000 USD
Sale 10 228.1100 USD
Sale 13 227.9969 USD
Sale 20 229.3800 USD
Sale 26 227.9140 USD
Sale 100 226.4400 USD
Sale 100 227.1400 USD
Sale 100 229.6710 USD
Sale 100 230.2700 USD
Sale 190 227.0441 USD
Sale 262 227.8417 USD
Sale 340 227.4301 USD
Sale 449 229.6361 USD
Sale 529 228.0614 USD
Sale 560 228.2158 USD
Sale 1,241 228.1538 USD
Sale 1,273 227.4199 USD
Sale 1,400 227.0135 USD
Sale 1,642 227.9352 USD
Sale 1,744 227.4200 USD
Sale 1,865 228.0977 USD
Sale 1,920 227.8282 USD
Sale 1,949 227.7274 USD
Sale 2,008 227.6027 USD
Sale 2,061 228.5958 USD
Sale 2,280 227.7340 USD
Sale 2,422 227.5055 USD
Sale 2,494 228.0158 USD
Sale 2,909 229.2076 USD
Sale 3,358 227.4637 USD
Sale 3,525 228.0533 USD
Sale 4,513 227.7861 USD
Sale 5,248 227.8690 USD
Sale 6,984 226.9679 USD
Sale 31,538 227.9024 USD
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant securities Price per unit
e.g. CFD (Note 6) (Note 7) (Note 5)
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5)
e.g. call option
(ii) Exercising
Product name, Number of securities Exercise price per unit (Note 5)
e.g. call option
(d) Other dealings (including transactions in respect of new securities) (Note
4)
Nature of transaction Details Price per unit
(Note 8) (if applicable) (Note 5)
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting
rights or future acquisition or disposal of any relevant securities to which
any derivative referred to on this form is referenced. If none, this should be
stated.
None
Is a Supplemental Form 8 (Open Positions) attached? YES
Date of disclosure: 15 Feb 2021
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection
Ap23
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or
Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
Product name Written or Number of Exercise Type Expiry
purchased relevant securities price date
to which the option
or derivative
relates
Call Options Purchased 6,000 220.0000 American Jul 16, 2021
Put Options Purchased -6,000 200.0000 American Jul 16, 2021
Notes
1. Where there are open option positions or open derivative positions (except
for CFDs), full details should be given. Full details of any existing
agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in
doubt, consult the Panel.
View source version on businesswire.com:
https://www.businesswire.com/news/home/20210215005192/en/
(https://www.businesswire.com/news/home/20210215005192/en/)
BARCLAYS PLC
Copyright Business Wire 2021Recent news on Barclays
See all newsREG - Barclays PLC British Land Co PLC - Form 8.3 BRITISH LAND COMPANY PLC, THE
AnnouncementREG - Barclays PLC IQE PLC - Form 8.3 IQE PLC
AnnouncementREG - Barclays PLC Intnl Personal Fin - Form 8.3 INTERNATIONAL PERSONAL FINANCE PLC
AnnouncementREG - Barclays PLC JTC PLC - Form 8.3 JTC PLC
AnnouncementREG - Barclays PLC Life Science REIT - Form 8.3 LIFE SCIENCE REIT PLC
Announcement